Meeting
2019 Gastrointestinal Cancers Symposium
A phase II study of ipilimumab and nivolumab with radiation in metastatic pancreatic adenocarcinoma.
Authors
Aparna Parikh
Massachusetts General Hospital, Boston, MA
Aparna Parikh , Jennifer Yon-Li Wo , David P. Ryan , Jeffrey W. Clark , Ryan David Nipp , Lawrence Scott Blaszkowsky , Colin D. Weekes , Emily Van Seventer , Leilana Ly , Bronwen Foreman , Ryan Bruce Corcoran , Theodore S. Hong
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Clinical Trial Registration Number
NCT03104439
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 391)
DOI
10.1200/JCO.2019.37.4_suppl.391
Abstract #
391
Poster Bd #
L11
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
A phase II study of nivolumab and ipilimumab with radiation therapy in patients with metastatic, microsatellite stable pancreatic adenocarcinoma.
First Author: Julie L. Koenig
Poster
2023 ASCO Annual Meeting
A phase II study of nivolumab and ipilimumab with radiation therapy in patients with metastatic, microsatellite stable colorectal cancer.
First Author: Julie L. Koenig
Poster
2019 ASCO Annual Meeting
A phase II study of ipilimumab and nivolumab with radiation in microsatellite stable (MSS) metastatic colorectal adenocarcinoma (mCRC).
First Author: Aparna Raj Parikh
Poster
2023 ASCO Annual Meeting
FLOT plus nivolumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: Results from the randomized phase 2 IKF-S628/AIO-STO-0417 (Moonlight) trial of the AIO.
First Author: Sylvie Lorenzen